Bio Techne (Brazil) Top Management
T1CH34 Stock | 13.08 0.36 2.68% |
Bio Techne employs about 3 K people. The company is managed by 10 executives with a total tenure of roughly 7000 years, averaging almost 700.0 years of service per executive, having 300.0 employees per reported executive. Analysis of Bio Techne's management performance can provide insight into the company performance.
Charles Kummeth CEO Pres CEO |
Bio |
Bio Techne Management Team Effectiveness
The company has return on total asset (ROA) of 0.0771 % which means that it generated a profit of $0.0771 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1483 %, meaning that it generated $0.1483 on every $100 dollars invested by stockholders. Bio Techne's management efficiency ratios could be used to measure how well Bio Techne manages its routine affairs as well as how well it operates its assets and liabilities.Bio Techne Workforce Comparison
Bio Techne is currently regarded as top stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 218,335. Bio Techne claims roughly 3,000 in number of employees contributing just under 2% to stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.23 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26. Bio Techne Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bio Techne Price Series Summation is a cross summation of Bio Techne price series and its benchmark/peer.
Bio Techne Notable Stakeholders
A Bio Techne stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bio Techne often face trade-offs trying to please all of them. Bio Techne's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bio Techne's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Charles Kummeth | Pres CEO | Profile | |
James Hippel | Exec CFO | Profile | |
Robert Gavin | VP Devel | Profile | |
Brenda JD | Gen VP | Profile | |
Brenda Everson | VP Officer | Profile | |
Gerry Andros | VP Marketing | Profile | |
Luca Cicchetti | Managing Director | Profile | |
Kim Kelderman | Pres Genomics | Profile | |
David Clair | Sr Devel | Profile | |
William Geist | Pres Segment | Profile |
About Bio Techne Management Performance
The success or failure of an entity such as Bio Techne often depends on how effective the management is. Bio Techne management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bio management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bio management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the presentation of Bio Techne's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bio Techne's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Bio Techne's management manipulating its earnings.
Bio Techne Workforce Analysis
Traditionally, organizations such as Bio Techne use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bio Techne within its industry.Bio Techne Manpower Efficiency
Return on Bio Techne Manpower
Revenue Per Employee | 368.5K | |
Revenue Per Executive | 110.6M | |
Net Income Per Employee | 90.7K | |
Net Income Per Executive | 27.2M |
Complementary Tools for Bio Stock analysis
When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |